ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ProMed Demonstrates Industry Leadership in Silicone Over Molding for Critical Medical Devices

ProMed, a recognized leader in precision manufacturing for regulated industries, continues to set benchmarks in the application of silicone over molding for medical devices.

-- ProMed, a recognized leader in precision manufacturing for regulated industries, continues to set benchmarks in the application of silicone over molding for medical devices. Silicone over molding, a specialized process that combines liquid silicone rubber with rigid substrates such as metals or high-performance plastics, enables the production of devices that demand exacting tolerances, durability, and reliable performance. This manufacturing approach is increasingly critical for devices exposed to repeated sterilization cycles, harsh environmental conditions, and high-use scenarios in medical settings.

ProMed’s expertise in silicone over molding is built on decades of experience in materials science, tooling design, and process optimization. The company’s facilities integrate advanced molding equipment with ISO 13485-certified cleanroom environments, ensuring that every component meets stringent regulatory and quality standards. The combination of mechanical interlocks, chemical adhesion techniques, and precise injection control allows for complex multi-material assemblies that maintain structural integrity and enhance functional reliability.

In the realm of medical device manufacturing, silicone over molding supports the creation of ergonomic grips, seals, and protective housings that improve both patient safety and clinician usability. The technique provides superior environmental sealing against moisture, chemicals, and temperature extremes while maintaining biocompatibility and compliance with FDA and ISO 10993 standards. These attributes are essential for applications ranging from implantable components to wearable health monitors and precision instruments.

ProMed’s process begins with meticulous substrate preparation and positioning, followed by controlled injection of liquid silicone. Both LSR (Liquid Silicone Rubber) and HCR (High Consistency Rubber) systems are employed depending on component size, complexity, and performance requirements. The careful selection of substrates, combined with precision molding parameters, ensures that finished components deliver consistent adhesion, dimensional stability, and long-term durability. This rigorous approach minimizes potential defects such as delamination or incomplete fills and supports high-yield, scalable production runs.

The company’s commitment to quality extends beyond manufacturing. Comprehensive validation, including IQ/OQ/PQ protocols, dimensional inspection with CMM and optical systems, and rigorous bond strength testing, ensures that all products meet or exceed industry standards. Environmental testing, biocompatibility evaluation, and sterilization validation further guarantee that each component performs reliably throughout its lifecycle. These measures establish confidence in the safety, performance, and regulatory compliance of devices produced using silicone over molding.

ProMed’s focus on process optimization also contributes to cost efficiency. By integrating substrates and silicone into single-molded components, labor-intensive assembly steps are reduced, part counts are minimized, and production scalability is enhanced. High-volume and low-volume projects alike benefit from consistent quality, reduced waste, and faster time-to-market, supporting both operational efficiency and financial return for clients.

Across the medical device sector, ProMed has applied its silicone over molding capabilities to a wide range of applications, including long-term implantable devices, diagnostic equipment, surgical instruments, and wearable medical technologies. The company’s expertise allows design teams to balance performance, ergonomics, and regulatory requirements without compromising on reliability or manufacturability. By combining advanced materials, precise tooling, and disciplined quality oversight, ProMed delivers components engineered for high-stakes, high-performance environments.

As demand for complex, reliable medical devices grows, silicone over molding has become an increasingly vital component of advanced manufacturing strategies. ProMed’s leadership in this field demonstrates the company’s ability to translate specialized expertise into tangible benefits for clients across regulated industries. Consistent product quality, robust mechanical performance, and adherence to regulatory standards position ProMed as a trusted partner for organizations seeking components that meet the most rigorous requirements.

About ProMed:
Since 1989, ProMed has been recognized as a leading Contract Manufacturer of complex, intricately designed molded silicone and plastic components and assemblies for highly regulated industries. ProMed’s expertise extends across applications for short-term and long-term implantable devices, single use devices, drug-releasing combination devices, and specialized materials and processes for defense applications.  We collaboratively work with our customers from prototype through production, providing over 30 years of experience related to design for manufacturability, material selection, tool and fixture design, process development, manufacturing, and other value-added services that result in cost-effective solutions with superior quality.


About the company: Since 1989, ProMed has been recognized as a leading Contract Manufacturer of complex, intricately designed molded silicone and plastic components and assemblies for highly regulated industries.

Contact Info:
Name: Kevin Roy
Email: Send Email
Organization: GreenBanana
Website: http://www.greenbananaseo.com

Release ID: 89173933

Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  230.30
+1.05 (0.46%)
AAPL  269.70
+0.70 (0.26%)
AMD  264.33
+6.32 (2.45%)
BAC  52.58
-0.29 (-0.55%)
GOOG  275.17
+6.74 (2.51%)
META  751.67
+0.23 (0.03%)
MSFT  541.55
-0.52 (-0.10%)
NVDA  207.04
+6.01 (2.99%)
ORCL  275.30
-5.53 (-1.97%)
TSLA  461.51
+0.96 (0.21%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.